Status | In progress |
Technology type | Medicine |
Decision | Selected |
Reason for decision | Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources |
Process | STA Standard |
ID number | 6497 |
Provisional Schedule
Committee meeting: 1 | 11 November 2025 |
Expected publication | 28 January 2026 |
Project Team
Project lead | Louise Jafferally |
Email enquiries
- If you have any queries please email TATeam4@nice.org.uk
Stakeholders
Companies sponsors | SIFI S.p.a. (polihexanide) |
Others | Department of Health and Social Care |
NHS England | |
Patient carer groups | Fight for Sight |
Professional groups | Association of Optometrists |
Neonatal and Paediatric Pharmacists Group | |
Royal College of Ophthalmologists | |
Royal College of Physicians | |
Associated public health groups | None |
Comparator companies | Thorton & Ross Ltd (propamidine) (confidentiality agreement not signed, not participating) |
General commentators | All Wales Therapeutics and Toxicology Centre |
British National Formulary | |
Department of Health - Northern Ireland | |
Healthcare Improvement Scotland | |
Medicines and Healthcare products Regulatory Agency | |
NHS Wales Joint Commissioning Committee | |
Scottish Medicines Consortium | |
Welsh Government | |
Relevant research groups | None |
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
11 April 2025 | Invitation to participate |
26 March 2025 | Topic routing was discussed at the NICE Prioritisation Board in March 2025. The Board concluded that the topic was suitable for a Technology Appraisal. Please see project documents for further details. |
26 March 2025 | Topic selection |
22 January 2025 - 19 February 2025 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6497 |
22 January 2025 | In progress. Scoping commenced. |
25 October 2024 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
For further information on our processes and methods, please see our CHTE processes and methods manual